Towards photon radiotherapy treatment planning with high Z nanoparticle radiosensitisation agents: the Relative Biological Effective Dose (RBED) framework
Title: | Towards photon radiotherapy treatment planning with high Z nanoparticle radiosensitisation agents: the Relative Biological Effective Dose (RBED) framework |
---|---|
Authors: | Jeremy M. C. Brown, Gerard G. Hanna, Nathanael Lampe, Balder Villagomez-Bernabe, James R. Nicol, Jonathan A. Coulter, Fred J. Currell |
Source: | Cancer Nanotechnology, Vol 9, Iss 1, Pp 1-13 (2018) |
Publisher Information: | BMC, 2018. |
Publication Year: | 2018 |
Collection: | LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
Subject Terms: | Radiotherapy, Nanoparticles, Treatment planning, Radiosensitisers, Biological effect modelling, Theranostic nanoparticles, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
More Details: | Abstract A novel treatment planning framework, the Relative Biological Effective Dose (RBED), for high Z nanoparticle (NP)-enhanced photon radiotherapy is developed and tested in silico for the medical exemplar of neoadjuvant (preoperative) breast cancer MV photon radiotherapy. Two different treatment scenarios, conventional and high Z NP enhanced, were explored with a custom Geant4 application that was developed to emulate the administration of a single 2 Gy fraction as part of a 50 Gy radiotherapy treatment plan. It was illustrated that there was less than a 1% difference in the dose deposition throughout the standard and high Z NP-doped adult female phantom. Application of the RBED framework found that the extent of possible biological response with high Z NP doping was great than expected via the dose deposition alone. It is anticipated that this framework will assist the scientific community in future high Z NP-enhanced in-silico, pre-clinical and clinical trials. |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 1868-6958 1868-6966 |
Relation: | http://link.springer.com/article/10.1186/s12645-018-0043-7; https://doaj.org/toc/1868-6958; https://doaj.org/toc/1868-6966 |
DOI: | 10.1186/s12645-018-0043-7 |
Access URL: | https://doaj.org/article/dc8bcf0877f34e35a7fc746e9975d94b |
Accession Number: | edsdoj.8bcf0877f34e35a7fc746e9975d94b |
Database: | Directory of Open Access Journals |
ISSN: | 18686958 18686966 |
---|---|
DOI: | 10.1186/s12645-018-0043-7 |
Published in: | Cancer Nanotechnology |
Language: | English |